170 material Form 8-K filings that 150 companies we cover made with the SEC in September 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Reynolds Consumer Products elected Rolf Stangl to its board of directors and named him non-executive Chairman effective September 23, 2024, filling the seat left by Richard Noll, who resigned on September 18, 2024. Stangl is a former CEO of SIG Group AG and currently sits on the board of Pactiv Evergreen Inc., and he was designated by the controlling stockholder, Packaging Finance Limited.
Rolf Stangl elected to the board effective September 23, 2024, as a Class III director with a term expiring at the 2026 annual meeting
Stangl appointed non-executive Chairman and a member of the CNG Committee, replacing Richard Noll, who resigned effective immediately on September 18, 2024
Stangl received restricted stock units with a grant date fair value of $122,547, vesting in full on September 23, 2025
Stangl was designated by Packaging Finance Limited, the controlling stockholder, under the Stockholders Agreement dated February 4, 2020
OFG Bancorp's board elected two new directors, Lynda Grindstaff and Roberto García, effective immediately on September 20, 2024. The board said the additions bring experienced members from different backgrounds, and the filing names their committee assignments.
Lynda Grindstaff and Roberto García were elected to the board on September 20, 2024, effective immediately.
Ms. Grindstaff joined the Risk and Compliance Committee.
Mr. García joined the Audit Committee and the Corporate Governance and Nominating Committee.
Their compensation will follow the non-executive director program described in the proxy statement.
Roivant's subsidiary Dermavant agreed on September 17, 2024 to be acquired by Organon for up to about $1.2 billion, including a $175 million payment at closing, a $75 million milestone on FDA approval of VTAMA for atopic dermatitis, and up to $950 million in sales-based milestones, plus tiered royalties. Roivant owns about 87% of Dermavant's shares, so the deal would deliver most of the proceeds to Roivant, though the amount depends on future milestones and the closing is subject to conditions.
Organon agreed to acquire Dermavant for up to about $1.2 billion in aggregate cash consideration, including a $175 million payment at closing
Additional $75 million payable on FDA approval of VTAMA for atopic dermatitis, and up to $950 million in tiered net sales milestones
Roivant owns approximately 87% of Dermavant's common and preference shares; shareholder written consent of at least 75% of voting rights was obtained
Expected to close in the fourth quarter of 2024; either party may terminate if not closed by March 17, 2025
Itron appointed David M. Wright, its Vice President and Corporate Controller, as Chief Accounting Officer with principal accounting officer duties previously held by CFO Joan S. Hooper. The board also approved a share repurchase program of up to $100 million over 18 months, which may be started or suspended without notice depending on market conditions.
David M. Wright, 54, approved as Vice President, Corporate Controller & Chief Accounting Officer by the board on September 19, 2024
Wright has been Vice President and Corporate Controller since May 2019 and rejoined Itron in September 2018
New share repurchase program authorizes up to $100 million of common stock over an 18-month period, effective September 19, 2024
No new material compensation arrangement was disclosed in connection with Wright's appointment
On September 20, 2024, Advent Convertible and Income Fund (AVK) began a rights offering that gives record-date shareholders one right per common share held, with one new common share available for every three rights. The filing says the offer covers up to 11,533,627 common shares, and the subscription price is set in the prospectus, which is not included in this filing text.
Record date was September 20, 2024; holders receive one right for each common share owned on that date.
Three rights are needed to buy one new common share, and holders who own fewer than three shares may buy one full share.
The offer covers up to 11,533,627 common shares, with UBS Securities LLC acting as dealer manager.
The rights are expected to trade on the NYSE under the symbol AVK RT.
Piper Sandler Companies elected Ann C. Gallo as a director effective September 23, 2024, and increased the board from ten to eleven members. Gallo previously led the healthcare investment team at Wellington Management, and the company says the healthcare sector is a key area for its investment banking, public finance and research businesses.
Ann C. Gallo elected to the board effective September 23, 2024, with an initial term expiring at the 2025 annual meeting
Board size increased from ten to eleven directors
Gallo's director pay includes a pro-rated $100,000 annual cash retainer, a $60,000 initial equity grant and a pro-rated $100,000 annual equity grant
Committee assignments are expected to be decided in February 2025
Horace Mann Educators named Ryan Greenier, currently Deputy CFO, as Executive Vice President and Chief Financial Officer, effective October 1, 2024, succeeding Bret Conklin, who plans to retire after remaining with the company through 2025. The filing also discloses a letter agreement under which CEO Marita Zuraitis's equity awards will fully vest upon separation or retirement if she stays through December 31, 2027, and bylaw amendments that add a stockholder advance notice requirement first applicable to the 2025 annual meeting.
Ryan Greenier, 42, becomes CFO effective October 1, 2024; his annual salary is $350,000 with an AIP target of 50% of eligible earnings and an LTIP target of $275,000.
Bret Conklin will remain through 2025 and serve as Executive Vice President, Finance Transformation.
CEO Marita Zuraitis's agreement, dated September 17, 2024, provides full vesting of equity awards at separation or retirement; it adds no incremental awards.
Advance notice window for 2025 annual meeting nominations: January 22, 2025 to February 21, 2025.
Q2 Holdings said its board appointed Jonathan A. Price, currently executive vice president of strategy and emerging businesses, as chief financial officer effective on or about November 6, 2024. He succeeds David J. Mehok, who is departing the company but will remain CFO through that date to assist with an orderly transition. The filing says Mehok's departure is not due to any dispute with Q2 over its operations, policies, practices or financial performance.
Price, 41, will become CFO and principal financial and accounting officer after Q2 files its Form 10-Q for the period ended September 30, 2024
Mehok will receive an incremental transition bonus of $90,000, payable over the 18 months after his departure, subject to his service through the transition date
No changes were made to Price's compensation or his employment agreement dated February 17, 2024
Responsibility for emerging businesses operations will transfer to Kirk Coleman, Q2's President
EPR Properties entered into a Fourth Amended, Restated and Consolidated Credit Agreement on September 19, 2024, providing a new $1.0 billion senior unsecured revolving credit facility with KeyBank as administrative agent. The new facility replaces the prior facility, extends its maturity to October 2, 2028, generally lowers the interest rate on loans, and removes the tangible net worth covenant. For shareholders, the filing describes improved borrowing terms and a $1.0 billion accordion feature, with $169.0 million drawn at September 19, 2024.
Facility size of $1.0 billion, with an accordion feature allowing an increase of $1.0 billion to $2.0 billion subject to lender consent
Maturity extended to October 2, 2028, with two six-month extension options for a total of 12 months
$169.0 million outstanding and $831.0 million available at the close of business on September 19, 2024
Interest rate generally reduced; the tangible net worth covenant was eliminated
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.